Organising
adaptive
immunity
We develop top-notch solutions for immune repertoire analysis starting from the sample preparation and ending with the leading software for extracting clinically relevant features from the data.
At MiLaboratories we focus on delivering the best solutions to investigators and clinicians to probe adaptive immunity in health and disease. Our MiXCR software is used in vaccine, cancer, antibodies and autoimmune diseases drug development pipelines. Backed up by our extensive experience in the field, we offer a full range of services starting from experiment planning, preparation of samples, sequencing to data processing and extracting clinically relevant features and diagnostic patterns.
FinD out more ↳
Announcing the Release of MiXCR 4.0, a Powerful Tool for Immunome Profiling
MiLaboratories, the global leader in immunome profiling software development, today announced the release of a new version of its flagship product, MiXCR 4.0. We believe our solution helps to achieve valuable insights for pharmaceuticals Research and Development teams around the globe and improve their drug discovery pipelines.
More details are available at Newswire.com↗
22 June, 2022MiLaboratories raises $2.3m seed from Speedinvest and Acrobator Ventures
Sunnyvale, CA, February 24, 2022. Our flagship product, MiXCR, is one of the most popular solutions in academia and pharmaceutical companies. It helps to analyze genomic diversity of antibodies and T-cell receptors. We now intensify product development towards advanced post-analysis tools including antibody hypermutation and single-cell transcriptomics. The investment round is led by Speedinvest↗ and Acrobator VC↗ with funds facilitating development of the next generation software - MiXCR Platform. New solution will be developed internally and provide unique functionality for delivering the most advanced genomics algorithms and data visualization directly to pharma and clinical professionals. This approach will revolutionize the bioinformatics industry, keep computational costs low, and deliver graphic interfaces for non-programmers. More details are available at Tech.eu↗
17 May, 2022ENPICOM and MiLaboratories
join forces
ENPICOM B.V↗, an innovative bioinformatics software engineering company, and MiLaboratories LLC, a technology leader in profiling the adaptive immune system, announced a strategic partnership↗ to enable efficient MiXCR integration into ENPICOM’s cloud-based IGX Platform↗. The partnership will allow MiXCR users to leverage its intuitive user interface and unique data management capabilities to store, analyze, visualize, and interpret immune repertoire sequencing data.
15 December, 2020MiLaboratories LLC launches TCR profiling for non-human primates
Service available for rhesus macaque (Macaca mulatta) and cynomolgus (crab-eating macaque, Macaca fascicularis). Phylogenetic closeness to humans makes non-human primates a model of choice for assessing the safety and efficiency of novel monoclonal antibodies and immunotherapeutic approaches. UMI-based TCR profiling allows to track the clonotype fates and alterations in TCR repertoire with the highest precision. Such analysis has become a tool of choice for in-depth monitoring of changes in the immune system in response to a certain therapy. High accuracy of our analysis helps practitioners to comply with modern ethical standards by reducing the required number of animals.
7 November, 2020MiXCR Immune Repertoire Analyzer version 2.1.11 is available at Illumina BaseSpace™
MiXCR, is now officially available↗ as an Illumina BaseSpace application↗ . “We are excited to work with MiLaboratory to offer their MiXCR pipeline on BaseSpace™ Sequence Hub”, said Kevin Meldrum, VP Product Development at Illumina. “We believe that this tool greatly complements our suite of bioinformatics pipelines and will help streamline analysis options for AmpliSeq™ for Illumina customers.”
4 November, 2019MiLaboratories LLC signed collaborative agreement with MIODx
MiLaboratories LLC and MIODx↗ , a well-known immunosequencing specialist, announced a collaboration agreement to expand the provision of services and product development. The companies will offer contract research projects in all applications related to sequencing-based probing of human and animal adaptive immune systems. Offered in the US and Europe, wet lab and dry lab services will range from sample preparations and library constructions to advanced analytics and reporting. More details here.
25 June, 2019MiLaboratory opens a US-based office
MiLaboratories LLC, registered in the United States, will become a MiLaboratory platform for more efficient penetration of the US and European markets. MiLaboratories LLC will offer a full range of bioinformatics services developed by MiLaboratory. This expansion will allow the company to reach and better serve existing and prospective customers.
21 June, 2019MiLaboratory publishes MiXCR RNA-Seq mode
MiXCR now allows you to efficiently extract immune repertoires from bulk RNA-Seq data↗ , yielding near-complete TCR repertoires from sorted T cells and abundant information on intratumoral immunoglobulin repertoires.
11 October, 2017